Recap: Corcept Therapeutics Q4 Earnings


Corcept Therapeutics CORT reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Corcept Therapeutics beat estimated earnings by 66.67%, reporting an EPS of $0.35 versus an estimate of $0.21.

Revenue was up $13.09 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1, which was followed by a 10.14% increase in the share price the next day.

Here's a look at Corcept Therapeutics's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 0.2 0.16 0.21 0.19
EPS Actual 0.3 0.30 0.20 0.27
Revenue Estimate 97.19M 86.84M 91.81M 87.77M
Revenue Actual 96.13M 91.59M 79.44M 85.73M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps